These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 7677930

  • 1. Treatment of colorectal neoplasia: clinicopathologic staging, management, and follow-up findings.
    Marks CG.
    Surg Annu; 1993; 25 Pt 1():127-40. PubMed ID: 7677930
    [No Abstract] [Full Text] [Related]

  • 2. Surgical strategies in the treatment of colorectal cancer.
    Bergamaschi R.
    Eur J Surg Suppl; 1995; (575):1-22. PubMed ID: 8963064
    [No Abstract] [Full Text] [Related]

  • 3. [Intraoperative staging of colorectal tumors].
    Abdurakhmonov IuB, Mel'nikov OR, Egorenkov VV, Moiseenko VM.
    Vopr Onkol; 2007; 53(2):210-4. PubMed ID: 17663177
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Experiences with quality assurance of the surgical treatment of colorectal carcinoma in the framework of' clinical care research].
    Lippert H.
    Chirurg; 2007 Jul; Suppl():218-9. PubMed ID: 18224757
    [No Abstract] [Full Text] [Related]

  • 9. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A, Höyhtyä M, Tavelin B, Stenling R, Lindmark G.
    Anticancer Res; 2000 Jul; 20(2B):1085-91. PubMed ID: 10810401
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G, Blomgren H.
    Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
    [Abstract] [Full Text] [Related]

  • 12. Current changes in the management and outcome of patients with curable colorectal cancer.
    Itah R, Greenberg R, Werbin N, Sacham-Shmueli E, Inbar R, Avital S.
    Isr Med Assoc J; 2011 May; 13(5):300-3. PubMed ID: 21845972
    [Abstract] [Full Text] [Related]

  • 13. Colorectal cancer. Nine-year experience.
    Berardi RS, Malette WG, Bradley RL, Dominguez F.
    Am J Proctol; 1973 Aug; 24(4):316-24. PubMed ID: 4731904
    [No Abstract] [Full Text] [Related]

  • 14. [Prognostic significance of metastatic lymph node ratio in colorectal cancer].
    Zhao Y, Li DC, Lou RC, Chen WP, Chen GP, Fan YT.
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):764-8. PubMed ID: 20021830
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma.
    Matsubara N, Hietala OA, Gilmour SK, Yum KY, Litwin S, Watts P, Brennan, O'Brien.
    Clin Cancer Res; 1995 Jun; 1(6):665-71. PubMed ID: 9816030
    [Abstract] [Full Text] [Related]

  • 17. [Prognostic factors of surgically treated colorectal cancer].
    Valleur P.
    Ann Gastroenterol Hepatol (Paris); 1996 Jun; 32(2):63-4. PubMed ID: 8737496
    [No Abstract] [Full Text] [Related]

  • 18. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
    Wang HS, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, Chang SC, Lin JK.
    Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641
    [Abstract] [Full Text] [Related]

  • 19. Surgical treatment and late results in 1,226 colorectal cancer cases.
    Zhou XG, Yu BM, Shen YX.
    Chin Med J (Engl); 1982 Jul; 95(7):483-90. PubMed ID: 6816516
    [No Abstract] [Full Text] [Related]

  • 20. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C, Bury J, Beauduin M, Herman ML, Vindevoghel A, Lecomte M, Brohée D, Canon JL, Focan-Henrard D, GRECCR Belgium.
    Anticancer Res; 2000 Jul; 20(6C):4665-72. PubMed ID: 11205198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.